Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop

• Egile Nagusiak: Xurxo García-Otero (Egilea), Victoria Díaz-Tomé (Egilea), Rubén Varela-Fernández (Egilea), Manuel Martín-Pastor (Egilea), Miguel González-Barcia (Egilea), José Blanco-Méndez (Egilea), Cristina Mondelo-García (Egilea), Maria A. Bermudez (Egilea), Francisco Gonzalez (Egilea), Pablo Aguiar (Egilea), Anxo Fernández-Ferreiro (Egilea), Francisco J. Otero-Espinar (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Uveitis is a vision inflammatory disorder with a high prevalence in developing countries. Currently, marketed treatments remain limited and reformulation is usually performed to obtain a tacrolimus eye drop as a therapeutic alternative in corticosteroid-refractory eye disease. The aim of this work w...